BOGANI, COSTANZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.517
EU - Europa 2.330
AS - Asia 872
SA - Sud America 107
Continente sconosciuto - Info sul continente non disponibili 42
AF - Africa 22
OC - Oceania 15
Totale 5.905
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.483
PL - Polonia 1.044
RU - Federazione Russa 465
IT - Italia 268
SG - Singapore 224
CN - Cina 215
HK - Hong Kong 158
SE - Svezia 148
IE - Irlanda 129
VN - Vietnam 94
BR - Brasile 79
DE - Germania 70
KR - Corea 57
GB - Regno Unito 44
IN - India 41
FR - Francia 38
FI - Finlandia 37
UA - Ucraina 30
CA - Canada 23
CH - Svizzera 21
JO - Giordania 15
AU - Australia 14
ID - Indonesia 12
TR - Turchia 10
BD - Bangladesh 9
BE - Belgio 9
JP - Giappone 9
NL - Olanda 8
ES - Italia 7
AR - Argentina 6
CL - Cile 6
AE - Emirati Arabi Uniti 5
IQ - Iraq 5
MA - Marocco 5
CI - Costa d'Avorio 4
MX - Messico 4
PK - Pakistan 4
VE - Venezuela 4
DZ - Algeria 3
EC - Ecuador 3
LT - Lituania 3
ZA - Sudafrica 3
CO - Colombia 2
CR - Costa Rica 2
EE - Estonia 2
EG - Egitto 2
GT - Guatemala 2
HN - Honduras 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
NG - Nigeria 1
NP - Nepal 1
PT - Portogallo 1
PW - Palau 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
Totale 5.864
Salva come PNG Salva come JPEG
Città #
Warsaw 1.043
Santa Clara 574
Ashburn 275
Fairfield 202
Singapore 156
Hong Kong 140
Chandler 137
Dublin 129
Woodbridge 101
Houston 90
Seattle 90
San Jose 87
Cambridge 75
Wilmington 72
Beijing 71
Ann Arbor 59
Seoul 57
Jacksonville 56
Milan 51
Buffalo 41
Ho Chi Minh City 37
Lawrence 33
Altamura 30
Princeton 30
Council Bluffs 29
Florence 27
Los Angeles 27
Dallas 25
Bern 21
Boston 21
Lauterbourg 21
Boardman 19
Hefei 19
Hanoi 18
Pune 18
Rome 18
Phoenix 17
Bremen 15
Dong Ket 15
Mumbai 15
Munich 15
New York 15
Shanghai 14
Melbourne 12
San Diego 10
The Dalles 10
Turku 10
Brussels 9
Frankfurt am Main 9
Medford 9
Jakarta 8
London 8
Montreal 8
Moscow 8
Tokyo 8
Clifton 7
Izmir 6
Salerno 6
São Paulo 6
Andover 5
Kent 5
Rignano sull'Arno 5
Santiago 5
Abidjan 4
Abu Dhabi 4
Cagliari 4
Chennai 4
Columbus 4
Falls Church 4
Figino 4
Naples 4
Norwalk 4
Orem 4
Palermo 4
Prato 4
Toronto 4
Turin 4
West Jordan 4
Amman 3
Atlanta 3
Basauri 3
Belo Horizonte 3
Bologna 3
Brooklyn 3
Cavriago 3
Chicago 3
Dhaka 3
Frankfurt Am Main 3
Guangzhou 3
Hangzhou 3
Hillsboro 3
Manchester 3
Padua 3
Redondo Beach 3
São José dos Campos 3
Sétif 3
Tampa 3
Amsterdam 2
Ariano Irpino 2
Baghdad 2
Totale 4.282
Salva come PNG Salva come JPEG
Nome #
Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial 346
Caratterizzazione di alterazioni molecolari relative alla patogenesi delle Neoplasie Mieloproliferative Croniche 338
Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives 335
Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. 327
B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosis. 326
mTOR inhibitors alone and in combination with JAK2 inhibitors effectively inhibit cells of myeloproliferative neoplasms. 324
Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis 318
Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis. 315
The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils of polycythemia vera. 288
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). 233
Overexpression of microRNA-16-2 contributes to the abnormalerythropoiesis in polycythemia vera. 232
MicroRNA expression profile in granulocytes from primary myelofibrosis patients. 221
Mitochondrial expression and functional activity of Breast Cancer Resistance Protein in different multiple drug-resistant cell lines 212
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in Primary Myelofibrosis 212
Inconsistencies in the association between the JAL2V617F mutation and PRV-1 over-expression among the chronic myeloproliferative diseases 204
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia. 204
Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms. 203
Breast cancer resistance protein (BCRP) expression and activity in mitochondria of different multiple drug-resistant (MDR) cancer cell lines 182
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden. 175
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. 172
Preclinical models for drug selection in myeloproliferative neoplasms. 166
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells unveils the role of miR-155/JARID2 axis in abnormal megakaryopoiesis. 162
JAK PI3K/mTOR COMBINATION THERAPY 154
Ruxolitinib is an effective treatment for CALR-positive patients with myelofibrosis 134
mTOR/JAK INHIBITOR COMBINATION THERAPY 122
Totale 5.905
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022209 0 0 31 11 9 13 5 16 8 12 47 57
2022/2023572 48 112 26 57 49 93 67 43 40 6 8 23
2023/2024203 6 20 27 18 22 58 3 31 2 2 8 6
2024/20251.432 23 139 86 193 422 256 18 92 59 20 50 74
2025/20261.208 177 160 100 77 149 53 153 44 64 66 32 133
2026/2027166 38 35 93 0 0 0 0 0 0 0 0 0
Totale 5.905